EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
13.35
+0.02 (0.15%)
At close: Sep 12, 2025, 4:00 PM EDT
13.20
-0.15 (-1.12%)
After-hours: Sep 12, 2025, 6:24 PM EDT
EyePoint Pharmaceuticals Employees
EyePoint Pharmaceuticals had 165 employees as of December 31, 2024. The number of employees increased by 44 or 36.36% compared to the previous year.
Employees
165
Change (1Y)
44
Growth (1Y)
36.36%
Revenue / Employee
$314,533
Profits / Employee
-$1,062,915
Market Cap
920.18M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 165 | 44 | 36.36% |
Dec 31, 2023 | 121 | -23 | -15.97% |
Dec 31, 2022 | 144 | 21 | 17.07% |
Dec 31, 2021 | 123 | 22 | 21.78% |
Dec 31, 2020 | 101 | 17 | 20.24% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EYPT News
- 11 days ago - EyePoint Pharmaceuticals, Inc. (EYPT) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
- 19 days ago - EyePoint Announces Participation at Upcoming Investor Conferences - GlobeNewsWire
- 26 days ago - EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - EyePoint Pharmaceuticals, Inc. (EYPT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - EyePoint to Present at the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 5 weeks ago - EyePoint Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Developments - GlobeNewsWire
- 6 weeks ago - EyePoint to Report Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewsWire
- 6 weeks ago - EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration - GlobeNewsWire